Audrey Strauss, the United States Attorney for the Southern District of New York, announced that SCOTT MANGINI has pleaded guilty today to conspiring to illegally distribute adulterated and mislabeled drugs with the intent to defraud and defraud mislead, in connection with the charges brought in United States v. Robinson et al., 20 Cr. 162 (JEA). MANGINI pleaded guilty before US District Judge J. Paul Oetken, and will be sentenced on September 10, 2021 before Judge Oetken.
US lawyer Audrey Strauss said: “Scott Mangini has created and inundated the supply of a greed market that continues to endanger racehorses through the sale of performance enhancing drugs. Mangini has designed and created dozens of products for use by those engaged in fraud and animal abuse. Its products have been manufactured without any monitoring of their composition, in substandard facilities, despite previous efforts by state and federal regulators to shut down Mangini’s operations and revoke its license. Mangini’s guilty plea underscores that our office and our FBI partners are committed to prosecuting and investigating corruption, fraud and endangerment in the horse racing industry.
Based on previous indictments, alternative information to which MANGINI has pleaded guilty, and other court documents, as well as statements made in public court proceedings:
From at least in or around 2011 until at least in or around March 2020, MANGINI and his conspirators manufactured, sold and shipped millions of dollars worth of adulterated and mislabeled equine drugs, including performance enhancing drugs (” PED ‘) intended for administration to racehorses for the purpose of improving the racing performance of those horses in order to win races and obtain cash prizes. MANGINI, a former pharmacist whose license was suspended in 2016, sold these drugs on several direct-to-consumer websites designed to appeal to trainers and racehorse owners, including “horseprerace.com” and “racehorsemeds.com “.
MANGINI was instrumental in the conspiracy by using, among other things, his training to design and create custom PEDs that were advertised and sold online, using deceptive labels, packaging and return address information, including sales. to customers in the Southern District of New York. Among the drugs advertised and sold during the plot were “blood builders,” which are used by racehorse trainers and others to increase the number of red blood cells and / or oxygenation of muscle tissue. a racehorse in order to boost the horse’s endurance. , which improves that horse’s performance and recovery after a race, as well as personalized pain relievers that are used by racehorse trainers and others to calm a horse’s nerves and block pain to improve the performance of a horse in the race. MANGINI and his co-conspirators have repeatedly touted the illegal drugs sold on these websites as substances that “WILL NOT BE TESTED” when tested for drugs by race officials. For example, MANGINI’s pain reliever product “Numb It Injection” has been touted as “a proprietary formulation and arguably the most potent pain injection on the market today AND WILL NOT TEST”, and customers have been expressly advised to administer the drug by “injection as close as possible to the event or extreme exercise.”
The drugs distributed on the Respondent’s websites were manufactured in facilities not approved by the Food and Drug Administration (“FDA”) and posed significant risks to animals affected by the administration of these illicit DEPs. For example, in 2016, MANGINI and his co-conspirator Scott Robinson, who had previously been convicted and convicted in this case, received a complaint about the effect of his unregulated drugs on a client’s horse: injection and for about 36 hours after that my two horses act like they are heavily sedated, can barely walk. Could I have a bad medicine bottle, I’m afraid to give more since this has happened three times. Commenting on this complaint to MANGINI, Robinson wrote simply: “here is another one”.
MANGINI is among 29 people indicted to date in a series of indictments resulting from an investigation into a widespread plan by racehorse trainers, vets, PED distributors and others to manufacture , to distribute and receive falsified and mislabeled PEDs and to secretly administer these PEDs to racehorses competing at all levels of professional horse racing. By circumventing PED bans and fooling regulators, horse racing officials, and the FDA, among others, participants in these programs have sought to improve racing performance and secure cash prizes from racetracks, all over the course of the year. to the detriment and risk of the health and welfare of racehorses.
* * *
MANGINI, 55, of Boca Raton, Fla., Pleaded guilty to one count of conspiring to violate federal laws on mislabelling and adulteration of drugs. This offense carries a maximum penalty of five years in prison. The potential maximum sentence is prescribed by Congress and is provided here for informational purposes only, as any conviction of the defendant will be determined by the judge.
Ms. Strauss praised the outstanding investigative work of the FBI New York Office’s Eurasian Organized Crime Task Force and its support for the FBI’s Sports and Gaming Integrity Initiative. Ms Strauss also thanked the New Jersey Attorney General’s Office, the New York State Police and the New York City Police Department for their support in this investigation, as well as the FDA and the Drug Enforcement Administration. from the United States for their help and expertise.
This case is being handled by the Office’s Money Laundering and Transnational Criminal Enterprises Unit. Deputy Prosecutors for the United States Sarah Mortazavi, Anden Chow, Benet Kearney and Andrew C. Adams are charged with the prosecution.